2021 BioMelbourne Network Annual General Meeting wrap
Posted: 1 December 2021 The 2021 BioMelbourne Network Annual General Meeting and Networking Event was held on Tuesday 30 November virtually via Zoom. Honorary Life Membership awards BioMelbourne Network bestows Honorary Life Membership awards on Members whose service…
A tribute to David Blake
The loss of David Blake has been felt deeply across our industry. Everyone at BioMelbourne Network would like to offer their heartfelt sympathies to his wife Sonya and daughter Alethea. Some of those who knew David best have shared their memories…
Breakthrough Funding To Boost Biotech Start-Ups
Posted 25 November 2021 Biotech start-ups in Melbourne are set to benefit from a new incubator in Parkville thanks to a substantial investment from the Andrews Labor Government’s Breakthrough Victoria Fund. The fund’s first investment will help local…
MedTech Actuator Origin Semi-Finalists announced
Posted 17 November 2021 Twenty impressive teams recently battled it out at the MedTech Actuator Origin Rapid Fire Rounds, pitching their ideas to improve and save lives through health innovation. Ten teams took out top place and are…
Governor of Victoria Startup Awards
Posted: 12 November Nominations close: 28 November The Governor of Victoria Startup Awards are supported by Her Excellency the Honourable Linda Dessau AC, Governor of Victoria, and will be presented at Government House in early 2022. The awards…
Florey Institute’s in-house legal counsel recognised by Association of Corporate Counsel Australia
Posted: 5 November 2021 Florey Institute of Neuroscience and Mental Health’s in-house legal counsel, Ms Charlotte Weld-Blundell, is a finalist in the Association of Corporate Counsel Australia’s corporate lawyer awards. Charlotte was recognised in the ‘New to In-House’…
Have your say on Australia’s Biotechnology Future
Posted: 5 November 2021 You’re invited to have your say on the Biotechnology Blueprint, the Australian biotechnology industry’s decadal strategy. The Biotechnology Blueprint (the Blueprint) is a shared vision for the industry, by the industry. Led by AusBiotech, and…
ANDHealth CEO Appointed as a Member of the Council of the NHMRC
Posted: 27 October 2021 BioMelbourne Network Member ANDHealth has announced that CEO and Managing Director, Bronwyn Le Grice, has been appointed by the Hon Greg Hunt, the Australian Minister for Health and Aged Care, as a Member of…
Amplia appoints leading drug developer as Oncology Clinical Advisor
Posted: 27 October 2021 Amplia Therapeutics has today announced the appointment of internationally renowned drug developer, José Iglesias M.D, as its Oncology Clinical Advisor. Click here to read today’s ASX release Dr Iglesias has over 33 years’ experience in…
AdAlta presentations at AusBiotech invest and BIO-Europe
Posted: 25 October 2021 BioMelbourne Network member, AdAlta Limited, the clinical stage drug discovery company developing novel therapeutic products from its i-body platform is pleased to announce that CEO and Managing Director, Dr Tim Oldham, will present at…
Applications are open for the 2022 BridgeTech Program
Posted: 22 October 2021 What are your professional development plans for 2022? Each year 80 people from a diverse range of professions and institutions around Australia are selected to join the BridgeTech Program, delivered by QUT. Fully funded…
Hemideina Completes $10m Series A Capital Raise
Posted 21 October 2021 Hemideina, a private hearing technology company and BioMelbourne Network member, has successfully closed its $10 million Series A Capital Raise, managed by Henslow. The fully subscribed capital raising positions the company to build out…
